Tag: Boston Scientific

Boston Scientific to buy cerebral protection system company

Boston Scientific has signed an agreement to acquire Claret Medical, which developed and commercialised the Sentinel cerebral embolic protection system. The device is used...

Boston Scientific to acquire Cryterion Medical

As part of its plan to expand it atrial fibrillation ablation therapy offering, Boston Scientific Corporation has announced a definitive agreement to acquire Cryterion...

Boston Scientific launches the HeartLogic heart failure diagnostic in Europe

Boston Scientific Europe has announced the launch of the HeartLogic Heart Failure Diagnostic in Europe. With this launch, the first and only diagnostic tool...

Real-world data demonstrates success of SMART Pass on the S-ICD System

Results from an analysis of the LATITUDE database which evaluated the successful reduction of inappropriate shocks using the SMART Pass sensing filter in patients...

Case report: Usefulness of high resolution mapping with mini-electrodes...

This article has been sponsored by Boston Scientific. Case description A 62-year-old woman, with recent sinus venosus atrial septal defect correction surgery, developed a persistent macroreentrant...

Clinical trial data further demonstrate safety and effectiveness of RHYTHMIA mapping...

Data from the TRUE-HD study has been announced during a late-breaking clinical trial session at the annual congress of the European Heart Rhythm Association...

Short-term DAPT is feasible for patients undergoing percutaneous LAA closure

Felix Weise (Cardioangiologisches Centrum Bethanien, Frankfurt, Germany) and others report in EuroIntervention that a strategy of six weeks’ duration of dual antiplatelet therapy (DAPT)...
PREVAIL watchman

TCT 2017: Boston Scientific reveals presentations at conference

Boston Scientific has announced key data will be presented at next week’s Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Denver, USA). For example,...

Boston Scientific announces agreement to acquire Apama Medical

Boston Scientific Corporation has announced a definitive agreement to acquire Apama Medical, a privately-held company that is developing the Apama Radiofrequency (RF) Balloon Catheter...

Boston Scientific gets FDA approval for MRI labelling and launches Resonate...

  Boston Scientific has launched the Resonate family of implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) systems featuring the HeartLogic Heart Failure...

Data confirm HeartLogic Diagnostic helps to categorise patients at low or...

Boston Scientific has announced new data from the MultiSENSE (Multisensor chronic evaluation in ambulatory heart failure patients) study, which is evaluating the performance of...

S-ICD technology continues to advance rapidly

The benefits of the Subcutaneous Implantable Cardioverter Defibrillator (S-ICD, Boston Scientific) over transvenous (TV)-ICD, including lower rates of lead-related complications and lower in-hospital complication...

HRS 2017: S-ICDs successful despite a range of comorbidities, and across...

Initial real-world experience with the S-ICD (subcutaneous implantable cardioverter defibrillator) in the USA show that implant success rate is high and short-term complications acceptably...

Boston Scientific receives US FDA approval for Resonate family of high-voltage...

The US Food and Drug Administration (FDA) has approved Boston Scientific’s Resonate family of implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D)...

Boston Scientific announces scheduled presentations at Heart Rhythm Society 2017

Boston Scientific has announced the schedule of key data presentations, including two late-breaking clinical trials that will be featured at the Heart Rhythm Society’s...

UK NICE recommends Boston Scientific CRT-D devices using EnduraLife battery technology

The National Institute for Health and Care Excellence (NICE) has issued medical technology guidance recommending the use of Boston Scientific’s cardiac resynchronisation therapy defibrillators...

Boston Scientific launches Resonate CRT-D platform in Europe

Boston Scientific has launched the Resonate cardiac resynchronisation therapy defibrillator (CRT-D) systems in Europe. This new family of devices features SmartCRT technology, which recently...

Educational supplement: LAA closure for stroke prophylaxis in atrial fibrillation

This educational supplement is only for readers in countries outside France, Japan and the USA In this educational supplement, sponsored by Boston Scientific, Cardiac Rhythm News explores left...

US FDA approves Boston Scientific Emblem MRI S-ICD system

Boston Scientific has received US Food and Drug Administration (FDA) approval for the Emblem MRI subcutaneous implantable defibrillator (S-ICD) system, as well as magnetic...